52407-92-8 Usage
General Description
3-Methyl-3,8-diaza-bicyclo[3.2.1]octane dihydrochloride, also known as JNJ-2408068, is a chemical compound with potential use as a therapeutic agent. It acts as a selective and potent antagonist of the neuropeptide Y2 receptor, which plays a role in regulating food intake and energy balance. In preclinical studies, this compound has shown promising results in reducing food intake and body weight in animal models, making it a potential candidate for the treatment of obesity and related metabolic disorders. Additionally, it may also have implications in the treatment of other conditions such as type 2 diabetes and cardiovascular diseases. Further research and clinical trials are needed to fully evaluate its safety and efficacy for human use.
Check Digit Verification of cas no
The CAS Registry Mumber 52407-92-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,4,0 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 52407-92:
(7*5)+(6*2)+(5*4)+(4*0)+(3*7)+(2*9)+(1*2)=108
108 % 10 = 8
So 52407-92-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H14N2.2ClH/c1-9-4-6-2-3-7(5-9)8-6;;/h6-8H,2-5H2,1H3;2*1H
52407-92-8Relevant articles and documents
CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS
-
Page/Page column 68, (2009/06/27)
The invention encompasses compounds of formula (I) as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV
Compounds for the Treatment of Hepatitis C
-
, (2008/12/06)
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
